RxDoctor Payments Data

Bryan Wilcox, MD

Otolaryngology · Layton, UTNPI 1891795779

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations.

$1,524in general payments, 2019–2025

Across 69 payments — averaging $22.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$347
  • Regeneron Healthcare Solutions, Inc.$163
  • Aerin Medical Inc.$153
  • Optinose US, Inc.$148
  • Medtronic$93
  • Kaleo, Inc.$88
  • plus $532 from 17 others

What the payments were for

  • Food & beverage$1,524100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,524 in reported general payments places this provider in the 55th percentile of 104 otolaryngology providers in Utah.

See all otolaryngology providers in Utah

Medicare billing

Part B allowed, 2024
$87,243
Medicare patients
227
Services billed
1,104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate12$17,306
Famotidine279$4,323
Fluticasone Propionate173$2,443
Pantoprazole Sodium222$2,220
Ipratropium Bromide69$1,667
Montelukast Sodium77$873
Ciprofloxacin Hcl46$461
CefuroximeCefuroxime Axetil30$461
Mometasone Furoate20$354
Nortriptyline Hcl18$339
Topiramate20$269
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid25$261
Mupirocin34$255
Levothyroxine Sodium20$206
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$151

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Layton

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →